相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells
Raviteja Inturi et al.
VIROLOGY (2021)
Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout
Shuai Zhen et al.
CANCER GENE THERAPY (2020)
Targeted Approaches for In Situ Gut Microbiome Manipulation
Gail A. M. Cresci et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2020)
The promise and challenge of therapeutic genome editing
Jennifer A. Doudna
NATURE (2020)
Continuous evolution of SpCas9 variants compatible with non-G PAMs
Shannon M. Miller et al.
NATURE BIOTECHNOLOGY (2020)
Gene editing and CRISPR in the clinic: current and future perspectives
Matthew P. Hirakawa et al.
BIOSCIENCE REPORTS (2020)
CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity
Iraj Mohammadzadeh et al.
IUBMB LIFE (2020)
Hyperbranched poly(β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer
Xueqin Gao et al.
JOURNAL OF CONTROLLED RELEASE (2020)
CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA
Caroline S. Binda et al.
VIRUSES-BASEL (2020)
Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression
Tanner Wiegand et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 74, 2020 (2020)
Prediction of the sequence-specific cleavage activity of Cas9 variants
Nahye Kim et al.
NATURE BIOTECHNOLOGY (2020)
CRISPR/CAS9-Mediated Antiviral Activity: A Tool to Combat Viral Infection
Usman Ali Ashfaq et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2020)
A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing
Apresio K. Fajrial et al.
THERANOSTICS (2020)
Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome
Saeedeh Ebrahimi et al.
REVIEWS IN MEDICAL VIROLOGY (2019)
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K. Gupta et al.
NATURE (2019)
Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9
Dmitry Kostyushev et al.
SCIENTIFIC REPORTS (2019)
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
Qiaoqiao Xiao et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
Choongho Lee
MOLECULES (2019)
Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9
Gigi C. G. Choi et al.
NATURE METHODS (2019)
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
Prasanta K. Dash et al.
NATURE COMMUNICATIONS (2019)
A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System
Anna Bellizzi et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)
Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors
Luqman Jubair et al.
MOLECULAR THERAPY (2019)
Engineered materials for in vivo delivery of genome-editing machinery
Sheng Tong et al.
NATURE REVIEWS MATERIALS (2019)
CRISPR-Cas9 in genome editing: Its function and medical applications
Saedeh Khadempar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6
Takahiro Yoshiba et al.
ONCOLOGY LETTERS (2019)
Molecular mechanisms in progression of HPV-associated cervical carcinogenesis
Sadhana M. Gupta et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
CRISPR-Cas Biology and Its Application to Infectious Diseases
Jeffrey R. Strich et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
HEPATITIS B VIRUS AND SITE-SPECIFIC NUCLEASES: EFFECTS OF GENETIC MODIFICATIONS IN CRISPR/Cas9 ON ANTIVIRAL ACTIVITY
A. P. Kostyusheva et al.
INFEKTSIYA I IMMUNITET (2019)
Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection
Ajeet Kaushik et al.
SCIENTIFIC REPORTS (2019)
SaCas9 Requires 5-NNGRRT-3 PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells
Haihua Xie et al.
BIOTECHNOLOGY JOURNAL (2018)
The Biology of CRISPR-Cas: Backward and Forward
Frank Hille et al.
CELL (2018)
Delivering CRISPR: a review of the challenges and approaches
Christopher A. Lino et al.
DRUG DELIVERY (2018)
Targeting HPV16 DNA using CRISPR/Cas inhibits anal cancer growth in vivo
David S. Hsu et al.
FUTURE VIROLOGY (2018)
CRISPR RNAs trigger innate immune responses in human cells
Sojung Kim et al.
GENOME RESEARCH (2018)
Towards HBV curative therapies
Raymond F. Schinazi et al.
LIVER INTERNATIONAL (2018)
Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection
Qiudi Deng et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Karin Hoppe-Seyler et al.
TRENDS IN MICROBIOLOGY (2018)
CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions
Makda Gebre et al.
VIRUSES-BASEL (2018)
SaCas9 Requires 5-NNGRRT-3 PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells
Haihua Xie et al.
BIOTECHNOLOGY JOURNAL (2018)
Gene Therapy for Chronic HBV-Can We Eliminate cccDNA?
Kristie Bloom et al.
GENES (2018)
One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
Maren Schiwon et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute
Yeh-Hsing Lao et al.
ADVANCED SCIENCE (2018)
Human Polyomaviruses and Papillomaviruses
Ugo Moens
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Johnny H. Hu et al.
NATURE (2018)
Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells
Yan-xiang Cheng et al.
CURRENT MEDICAL SCIENCE (2018)
The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing
Hadi Bayat et al.
CURRENT MICROBIOLOGY (2018)
CRISPR/Cas9-The ultimate weapon to battle infectious diseases?
M. Doerflinger et al.
CELLULAR MICROBIOLOGY (2017)
Efficient inhibition of duck hepatitis B virus DNA by the CRISPR/Cas9 system
Qingfen Zheng et al.
MOLECULAR MEDICINE REPORTS (2017)
Human papillomavirus molecular biology
Mallory E. Harden et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2017)
Delivery technologies for genome editing
Hao Yin et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Oncogenic human papillomaviruses
Alison A. McBride
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans
Jasper Adriaan Soppe et al.
TRENDS IN MICROBIOLOGY (2017)
Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9
Takeshi Kurihara et al.
SCIENTIFIC REPORTS (2017)
The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication
Jie Wang et al.
THERANOSTICS (2017)
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection
Zhepeng Liu et al.
CELL AND BIOSCIENCE (2017)
Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9
Hao Li et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells
Tristan Scott et al.
SCIENTIFIC REPORTS (2017)
Using CRISPR-Cas systems as antimicrobials
David Bikard et al.
CURRENT OPINION IN MICROBIOLOGY (2017)
Antivirals against animal viruses
T. G. Villa et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Treatment of hepatitis B virus with combination therapy now and in the future
Joel S. Emery et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Inhibition of CRISPR-Cas9 with Bacteriophage Proteins
Benjamin J. Rauch et al.
CELL (2017)
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker et al.
SCIENCE (2016)
Reprogrammed CRISPR-Cas9 targeting the conserved regions of HPV6/11 E7 genes inhibits proliferation and induces apoptosis in E7-transformed keratinocytes
Yu-Chen Liu et al.
ASIAN JOURNAL OF ANDROLOGY (2016)
Improved antiviral efficacy using TALEN-mediated homology directed recombination to introduce artificial primary miRNAs into DNA of hepatitis B virus
Timothy Dreyer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Naturally Occurring Off-Switches for CRISPR-Cas9
April Pawluk et al.
CELL (2016)
Highly multiplexed CRISPR-Cas9-nuclease and Cas9-nickase vectors for inactivation of hepatitis B virus
Tetsushi Sakuma et al.
GENES TO CELLS (2016)
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA
Christoph Seeger et al.
MOLECULAR THERAPY (2016)
BIOTECHNOLOGY Embryo editing gets green light
Ewen Callaway
NATURE (2016)
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver et al.
NATURE (2016)
Applications of CRISPR technologies in research and beyond
Rodolphe Barrangou et al.
NATURE BIOTECHNOLOGY (2016)
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
Prarthana Mohanraju et al.
SCIENCE (2016)
In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line
Shuai Zhen et al.
TRANSLATIONAL ONCOLOGY (2016)
CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse
Wei Zhu et al.
VIRUS RESEARCH (2016)
Engineering Delivery Vehicles for Genome Editing
Christopher E. Nelson et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 7 (2016)
Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape
Martyn K. White et al.
PLOS PATHOGENS (2016)
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems
Julia K. Bialek et al.
PLOS ONE (2016)
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kaminski et al.
SCIENTIFIC REPORTS (2016)
A 'suicide' CRISPR-Cas9 system to promote gene deletion and restoration by electroporation in Cryptococcus neoformans
Yu Wang et al.
SCIENTIFIC REPORTS (2016)
Genome editing: the road of CRISPR/Cas9 from bench to clinic
Ayman Eid et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
Chunsheng Dong et al.
ANTIVIRAL RESEARCH (2015)
New approaches to HIV vaccine development
Barton F. Haynes
CURRENT OPINION IN IMMUNOLOGY (2015)
The therapeutic application of CRISPR/Cas9 technologies for HIV
Sheena Saayman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus
S. Zhen et al.
GENE THERAPY (2015)
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Michael Nassal
GUT (2015)
Progress and Prospects of Anti-HBV Gene Therapy Development
Mohube B. Maepa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
Xing Liu et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Genome editing strategies: potential tools for eradicating HIV-1/AIDS
Kamel Khalili et al.
JOURNAL OF NEUROVIROLOGY (2015)
Rational design of a split-Cas9 enzyme complex
Addison V. Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
Weijun Zhu et al.
RETROVIROLOGY (2015)
A Cas9-guide RNA complex preorganized for target DNA recognition
Fuguo Jiang et al.
SCIENCE (2015)
Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
Edward M. Kennedy et al.
VIROLOGY (2015)
Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
Jie Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
Hsin-Kai Liao et al.
NATURE COMMUNICATIONS (2015)
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
Vyas Ramanan et al.
SCIENTIFIC REPORTS (2015)
CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
Madina Karimova et al.
SCIENTIFIC REPORTS (2015)
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
Panpan Hou et al.
SCIENTIFIC REPORTS (2015)
RNA interference approaches for treatment of HIV-1 infection
Maggie L. Bobbin et al.
GENOME MEDICINE (2015)
被撤回的出版物: Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells(Retracted article.See vol.10, pg.2835-2835, 2017)
Lan Yu et al.
ONCOTARGETS AND THERAPY (2015)
In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9
Shuai Zhen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
Hiroshi Nishimasu et al.
CELL (2014)
A risk for non-sexual transmission of human papillomavirus?
Eric J. Ryndock et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Multiple genome modifications by the CRISPR/Cas9 system in zebrafish
Satoshi Ota et al.
GENES TO CELLS (2014)
One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering
Jiankui Zhou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Gene therapy and DNA delivery systems
D. Ibraheem et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Gold Nanoparticles for Nucleic Acid Delivery
Ya Ding et al.
MOLECULAR THERAPY (2014)
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Gilad Doitsh et al.
NATURE (2014)
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Robert J. Citorik et al.
NATURE BIOTECHNOLOGY (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
Classification and evolution of type II CRISPR-Cas systems
Krzysztof Chylinski et al.
NUCLEIC ACIDS RESEARCH (2014)
Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules
Samad Mussa Farkhani et al.
PEPTIDES (2014)
AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
Nicholas D. Weber et al.
PLOS ONE (2014)
CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection
Weiming Wang et al.
PLOS ONE (2014)
Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
Lin Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Short- and long-term outcome of interferon therapy for chronic hepatitis B infection
Yasushi Seo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatitis B virus genotypes: Global distribution and clinical importance
Mustafa Sunbul
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Current Progress in Gene Delivery Technology Based on Chemical Methods and Nano-carriers
Lian Jin et al.
THERANOSTICS (2014)
Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
Zheng Hu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
Su-Ru Lin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Targeting Hepatitis B Virus With CRISPR/Cas9
Christoph Seeger et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Physical Non-Viral Gene Delivery Methods for Tissue Engineering
Adam J. Mellott et al.
ANNALS OF BIOMEDICAL ENGINEERING (2013)
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Seung Woo Cho et al.
NATURE BIOTECHNOLOGY (2013)
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
Vikram Pattanayak et al.
NATURE BIOTECHNOLOGY (2013)
POLYMER NANOPARTICLES Weighing up gene delivery
Ameya R. Kirtane et al.
NATURE NANOTECHNOLOGY (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Possible origins and evolution of the hepatitis B virus (HBV)
Stephen Locarnini et al.
SEMINARS IN CANCER BIOLOGY (2013)
Newer Gene Editing Technologies toward HIV Gene Therapy
N. Manjunath et al.
VIRUSES-BASEL (2013)
Advances in antiretroviral therapy
Jose R. Arribas et al.
CURRENT OPINION IN HIV AND AIDS (2013)
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Hirotaka Ebina et al.
SCIENTIFIC REPORTS (2013)
Emerging Infectious Diseases: Threats to Human Health and Global Stability
David M. Morens et al.
PLOS PATHOGENS (2013)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
RNA-guided genetic silencing systems in bacteria and archaea
Blake Wiedenheft et al.
NATURE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Update on Human Immunodeficiency Virus (HIV)-2 Infection
Omobolaji T. Campbell-Yesufu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Plant and Animal Steroids a New Hope to Search for Antiviral Agents
V. Castilla et al.
CURRENT MEDICINAL CHEMISTRY (2010)
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Josiane E. Garneau et al.
NATURE (2010)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Oncogenic activities of human papillomaviruses
Margaret E. McLaughlin-Drubin et al.
VIRUS RESEARCH (2009)
DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells
Zhiyong Mao et al.
CELL CYCLE (2008)
Cross-species virus transmission and the emergence of new epidemic diseases
Colin R. Parrish et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
Animal-based medicines: biological prospection and the sustainable use of zootherapeutic resources
EM Costa-Neto
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2005)
Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS
JB Alimonti et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
分享论文
